Clinical Trials Logo

Undefined clinical trials

View clinical trials related to Undefined.

Filter by:

NCT ID: NCT06336876 Recruiting - Undefined Clinical Trials

Perceived Coping, Meaning, and Joy at Work

Start date: June 30, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to assess and describe employee characteristics associated with perceived horizontal inter-collegial workplace uncivil behavior within nursing services, and identify any relationships with meaning and joy in work (MJW), and assess job satisfaction.

NCT ID: NCT06216912 Recruiting - Undefined Clinical Trials

Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy

Start date: January 10, 2024
Phase:
Study type: Observational

Preoperative preoxygenation is performed using High-flow nasal oxygen therapy, and the gastric volume before and after High-flow nasal oxygen therapy is measured by ultrasound and compared in obese patients undergoing surgery under general anesthesia.

NCT ID: NCT05675930 Recruiting - Clinical trials for Graft-Versus-Host Disease

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Start date: December 22, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether photobiomodulation/PBM therapy using the Thor LX2.3 therapy system is a safe and effective treatment for oral Graft-Versus-Host Disease/GVHD.

NCT ID: NCT05158985 Recruiting - Undefined Clinical Trials

Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis

Start date: May 15, 2020
Phase: N/A
Study type: Interventional

Lateral epicondylitis is a tendinopathy injury involving the extensor muscles of the forearm. These muscles originate on the lateral epicondylar region of the distal humerus. the insertion of the extensor carpi radialis brevis is involved in most cases. Transdermal administration of an anti-inflammatory drug to specific area is one of the methods that used to decrease inflammation and increase cell metabolism

NCT ID: NCT04905095 Recruiting - Undefined Clinical Trials

CSAPG Early Warning Score

CEWS
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The Early Warning Score (EWS) has been shown in previous studies to be correlated with mortality and mean hospital stay, but it is unknown whether the implementation of the scale improves mortality and mean hospital stay. This trial aims to study whether the implantation of the EWS in a regional hospital reduces the mean hospital stay (primary objective), mortality and complications (secondary objectives). For this, an open clinical trial will be carried out in which the hospitalization floors of the hospital will be administratively divided into two sections (two study branches); the EWS scale will be implemented in the computer equipment of one of the sections of each floor, acting the another section as a control branch. All the patients admitted to the participating hospital floors during one year will be included in the study. The mean stay, mortality and complications will be compared between study branches.

NCT ID: NCT04659122 Terminated - COVID-19 Clinical Trials

A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia

Start date: August 17, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if an investigational drug, AT-100, is safe and tolerated by adults who have severe corona virus disease 2019 (COVID-19) or respiratory failure secondary to severe community acquired pneumonia.

NCT ID: NCT04438356 Completed - Anxiety Clinical Trials

M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness

Start date: July 22, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to explore the overall effectiveness of interventions using mobile health care to improve disease perception, self-efficacy, anxiety, cardio-pulmonary fitness for patients with acute myocardial infarction.

NCT ID: NCT04349761 Completed - Undefined Clinical Trials

Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects

Start date: June 11, 2019
Phase: Phase 1
Study type: Interventional

Double-blind, placebo-controlled, First-in-Human, single ascending-dose study. Approximately 40 healthy adult male subjects will be given a single capsule of MYMD1 to determine its safety, how well it is tolerated, how the body acts on the experimental drug, and how the experimental drug acts on the body. This will be based on blood and urine sample analysis and other physical measurements.

NCT ID: NCT04029662 Completed - Undefined Clinical Trials

Reducing Pain Intensity During Spinal Needle Insertion: Valsalva Maneuver vs. Control Technique

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

This study was aimed to observe the efficacy of Valsalva maneuver in reducing pain intensity during spinal needle insertion.

NCT ID: NCT03937583 Recruiting - Pulmonary Embolism Clinical Trials

Screening for Cancer in Patients With Unprovoked VTE

SOME-RIETE
Start date: October 23, 2019
Phase: Phase 4
Study type: Interventional

Open and multicenter randomized clinical trial (1:1) comparing limited screening with extended screening with the performance of Positron emission tomography-computed tomography (PET-CT) scan in the search for neoplasms in patients with unprovoked venous thromboembolic disease at high risk of developing cancer at follow-up. Introduction: Cancer screening in patients with unprovoked venous thromboembolic disease (VTE) is controversial. In the last years, a score has been developed that selects patients at high risk of developing cancer during follow-up. Objective: To estimate the impact of an active cancer search strategy using 18-fluordesoxiglucose (FDG) PET-CT in unprovoked VTE with high-risk to develop cancer. Specific Objectives: 1) Number of neoplasms diagnosed in the screening process: 2) number of neoplasms diagnosed at an early stage, 3) impact on survival of the strategy; and 4) impact on the quality of life. Cancer will be considered from 30 days up to 12 months after the diagnosis of VTE. Scope: 20 Spanish hospitals. Design: Open-label, multicentre Randomized clinical trial (1: 1) comparing the performance of PET-CT versus limited screening for cancer. Population: Patients older than 18 years with unprovoked VTE at high risk of presenting cancer at follow-up (≥3 points in the score of Jara-Palomares et al., Chest 2017). Follow-up: 12 months after VTE. Sample: The sample size calculated is 650 patients, to obtain a power of 80%, with a level of significance of 5%, and taking into account a 10% loss of follow-up.